SCHEMBL5864858

SCHEMBL5864858

CCOC(=O)CS(=O)(=O)Nc1ccc(OC2C[C@H]3CC[C@@H](C2)N3C)c(Cl)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RORC P51449 1/20 0.46
P2RX3 P56373 6/20 0.44
SCN1A P35498 3/20 0.38
SCN8A Q9UQD0 3/20 0.38
LMNA P02545 2/20 0.38
KDM4E B2RXH2 1/20 0.38
CYP2D6 P10635 2/20 0.38
TSHR P16473 2/20 0.38
MAPT P10636 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
ALDH1A1 P00352 1/20 0.38
ERBB2 P04626 1/20 0.38
FLT1 P17948 1/20 0.38
EPHA2 P29317 1/20 0.38
KDR P35968 1/20 0.38
EPHB4 P54760 1/20 0.38
MEN1 O00255 1/20 0.38
PMP22 Q01453 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5864860 1.00 RORC (0.46) RORCP2RX3SCN1ASCN8ALMNA
SCHEMBL5864995 0.87 RORC (0.49) RORCP2RX3LMNAKDM4EERBB2
SCHEMBL5865267 0.85 RORC (0.43) RORCP2RX3SCN1ASCN8ALMNA
SCHEMBL5864758 0.85 RORC (0.47) RORCP2RX3SCN1ASCN8AMEN1
SCHEMBL5865064 0.85 RORC (0.48) RORCP2RX3SCN1ASCN8ALMNA
SCHEMBL5865179 0.84 HRH1 (0.47) RORCP2RX3SCN8AALDH1A1
SCHEMBL5864987 0.84 SMN1; SMN2 (0.49) RORCP2RX3LMNAALDH1A1MEN1
SCHEMBL5864927 0.84 RORC (0.50) RORCP2RX3LMNAKDM4EMAPT
SCHEMBL5864923 0.83 RORC (0.45) RORCP2RX3SCN1ASCN8ALMNA
SCHEMBL5865205 0.83 RORC (0.47) RORCP2RX3LMNAKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7030138-B2 Benzamidine derivatives SANKYO COMPANY, LIMITED (JP) 2006-04-18 US disclosed
US-20040147555-A1 Benzamidine derivatives SANKYO COMPANY, LIMITED (JP) 2004-07-29 US disclosed
EP-1375482-A1 BENZAMIDINE DERIVATIVE Sankyo Company, Limited (JP) 2004-01-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040147555-A1 Benzamidine derivatives F9, F7, F2 RORC 4836/4885P2RX3 3071/4885SCN1A 572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.